Luminex Corp (LMNX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

12212 TECHNOLOGY BLVD AUSTIN, TX 78727

Makes and markets compact analyzers that simultaneously perform numerous bioassays on a single drop of fluid by reading biological tests taking place on the surface of microscopic polystyrene beads called microspheres. The analyzers integrate fluidics, optics and digital signal processing.

Data as of 2020-09-12
Market Cap1.147 Billion Shares Outstanding46.363 Million Avg 30-day Volume875.697 Thousand
P/E Ratio104.9 Dividend Yield1.455 EPS0.23
Price/Sales3.107 Price cash flow ratio27.9 Price free cash flow ratio1721.1
Book Value10.88 Price to Tangible Book3.78 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.059524
BETA0.586966 52-week High/Low41.69 / 17.345 Stddev0.102796
View SEC Filings from LMNX instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 4 -25.0% 1 (0.07%) 1 (0.06%) 0.0%
Funds Holding: 206 169 21.89% 65 (4.24%) 49 (3.13%) 32.65%
13F shares: 43.253 Million 36.78 Million 17.6% 17.753 Million 12.69 Million 39.91%
% Ownership 93.2914 80.781 15.49% 38.292 27.87 37.4%
New Positions: 53 33 60.61% 20 15 33.33%
Increased Positions 67 60 11.67% 26 10 160.0%
Closed Positions 15 25 -40.0% 4 8 -50.0%
Reduced Positions 58 50 16.0% 16 20 -20.0%
Total Calls 325.435 Thousand 40.264 Thousand 708.25% 211.5 Thousand 13.2 Thousand 1502.27%
Total Puts 709 10.754 Thousand -93.41%
PUT/CALL Ratio 0.0 0.27 -100.0% 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LMNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LMNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

360.8 Thousand total shares from 9 transactions

Exercise Derivative Conversion (M)

286.5 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FAIRCHILD NANCY SVP, HUMAN RESOURCES

  • Officer
33,828 2020-08-05 6

SHAPIRO ERIC SR VP, GLOBAL MARKETING

  • Officer
33,867 2020-08-05 2

LOEWENBAUM G WALTER II

  • Director
1,684,990 2020-08-04 11

SHAMIR NACHUM PRESIDENT & CEO

  • Officer
  • Director
189,632 2020-08-03 4

REW RICHARD W. II SVP, GEN COUNSEL & CORP SECY

  • Officer
33,153 2020-08-03 3

MYERS RANDALL SVP, GLOBAL MFG AND QUALITY

  • Officer
34,138 2020-07-17 6

COLLINS CHARLES J. SR VP, R&D - US

  • Officer
34,554 2020-07-17 4

MCNAMARA KEVIN M

  • Director
98,293 2020-06-01 1

KEVER JIM D

  • Director
229,295 2020-06-01 1

ERICKSON THOMAS W

  • Director
185,806 2020-06-01 1

OGUNRO EDWARD A

  • Director
58,919 2020-06-01 1

ECK STEPHEN L.

  • Director
32,339 2020-06-01 1

SAMET KENNETH A

  • Director
19,620 2020-06-01 1

LEWIS DIJUANA K

  • Director
6,955 2020-06-01 2

CURRIE HARRISS T SVP, FINANCE & CFO

  • Officer
225,817 2020-03-11 2

BENNETT TODD C. SVP, GLOBAL SALES & CUST OPS

  • Officer
34,133 2020-03-11 1

CRESCI ROBERT J

  • Director
220,157 2018-05-17 0

LAZARUS TADD S. SVP, CHIEF MEDICAL OFFICER

  • Officer
10,495 2017-03-10 0

JOHNSTON JAY B

  • Director
146,696 2016-05-19 0

BRADLEY RUSSELL W SVP, CORP DEV & CMO

  • Officer
100,667 2016-03-22 0

GOAD FRED C JR

  • Director
300,767 2015-05-14 0

BRIDGE-COOK JEREMY K SVP, RESEARCH AND DEVELOPMENT

  • Officer
74,273 2015-03-12 0

BALTHROP PATRICK J PRESIDENT & CEO

  • Officer
  • Director
646,873 2014-05-14 0

REITER DAVID S SVP & GENERAL COUNSEL

  • Officer
60,400 2014-05-01 0

PINTEK MICHAEL F SVP, OPERATIONS

  • Officer
62,236 2014-03-13 0

DEHNE TIMOTHY R VP, SYSTEMS R&D

  • Officer
20,441 2013-08-16 0

VAILLANT GERARD

  • Director
61,842 2012-05-23 0

GOSCH GREGORY J VP, BIOSCIENCE GROUP

  • Officer
55,380 2010-05-13 0

THOMPSON J STARK PHD

  • Director
18,289 2008-11-26 0

CARRANO JOHN C VP, RESEARCH & DEVELOPMENT

  • Officer
43,913 2008-11-17 0

BRYANT DOUGLAS C EVP, CHIEF OPERATING OFFICER

  • Officer
68,428 2008-05-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SHAPIRO ERIC - Officer SR VP, GLOBAL MARKETING

2020-08-06 09:24:03 -0400 2020-08-05 M 14,179 $16.74 d 0 direct

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-05 M 11,176 $15.93 d 11,176 direct

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-05 S 11,176 $40.93 d 33,153 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-05 M 8,559 $15.93 d 0 direct

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-05 S 8,559 $40.16 d 189,632 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAPIRO ERIC - Officer SR VP, GLOBAL MARKETING

2020-08-06 09:24:03 -0400 2020-08-05 S 14,179 $40.16 d 33,867 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-05 M 11,176 $15.93 a 44,329 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-05 M 8,559 $15.93 a 197,583 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

FAIRCHILD NANCY - Officer SVP, HUMAN RESOURCES

2020-08-06 09:22:59 -0400 2020-08-05 S 24,283 $40.16 d 33,828 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAPIRO ERIC - Officer SR VP, GLOBAL MARKETING

2020-08-06 09:24:03 -0400 2020-08-05 M 14,179 $16.74 a 48,046 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-04 M 3,786 $15.93 a 36,939 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-04 M 116,441 $15.93 a 305,465 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

LOEWENBAUM G WALTER II - Director

2020-08-06 13:08:45 -0400 2020-08-04 S 50,000 $39.02 d 450,441 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-04 M 3,786 $15.93 d 22,352 direct

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-04 M 116,441 $15.93 d 8,559 direct

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-04 S 3,786 $38.93 d 33,153 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-04 S 116,441 $39.50 d 189,024 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-03 M 125,000 $15.93 a 314,024 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-03 S 7,389 $38.93 d 33,153 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-03 S 125,000 $38.51 d 189,024 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-03 M 7,389 $15.93 d 26,138 direct

REW RICHARD W. II - Officer SVP, GEN COUNSEL & CORP SECY

2020-08-05 18:55:01 -0400 2020-08-03 M 7,389 $15.93 a 40,542 direct -3.2005 -3.5628 -23.6715 0.0 1 -27.4457 22

SHAMIR NACHUM - Director - Officer PRESIDENT & CEO

2020-08-05 18:56:28 -0400 2020-08-03 M 125,000 $15.93 d 125,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments